Table 2.

Treatment-related AEs occurring in >1 patient.

CharacteristicAny grade (N = 50)Grade 3/4 (N = 50)
≥1 TRAE, n (%)34 (68.0)11 (22.0)
 Thrombocytopenia20 (40.0)10 (20.0)
 Fatigue/asthenia8 (16.0)1 (2.0)
 Neutropeniaa6 (12.0)4 (8.0)
 Vomiting3 (6.0)0
 Constipation2 (4.0)0
 Nausea2 (4.0)0
 Decreased appetite2 (4.0)0
 Dysgeusia2 (4.0)0
 Conjunctival hemorrhage2 (4.0)0
 Pruritus2 (4.0)0
 Rash maculopapular2 (4.0)0
  • Abbreviation: TRAE, treatment-related AE.

  • aNeutropenia only occurred after clinically significant thrombocytopenia and not as an isolated event.